| Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults A Singh, A Gupta, EM DeFilippis, A Qamar, DW Biery, Z Almarzooq, ... Journal of the American College of Cardiology 75 (9), 1003-1013, 2020 | 58 | 2020 |
| Causes of troponin elevation and associated mortality in young patients C Wu, A Singh, B Collins, A Fatima, A Qamar, A Gupta, J Hainer, J Klein, ... The American journal of medicine 131 (3), 284-292. e1, 2018 | 34 | 2018 |
| Identifying familial hypercholesterolemia using a blood donor screening program with more than 1 million volunteer donors CL Jackson, JZ Keeton, SJ Eason, ZA Ahmad, CR Ayers, MO Gore, ... JAMA cardiology 4 (7), 685-689, 2019 | 22 | 2019 |
| Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis CL Jackson, T Huschka, B Borah, K Agre, M Zordok, M Farwati, J Moriarty, ... American Journal of Preventive Cardiology 8, 100245, 2021 | 18 | 2021 |
| Sorafenib-associated heart failure complicated by cardiogenic shock after treatment of advanced stage hepatocellular carcinoma: a clinical case discussion C Wu, K Shemisa Case Reports in Cardiology 2017, 2017 | 17 | 2017 |
| Familial hypercholesterolemia in Southeast and East Asia CL Jackson, M Zordok, IJ Kullo American Journal of Preventive Cardiology 6, 100157, 2021 | 11 | 2021 |
| Platelet Btk is required for maintaining lung vascular integrity during murine pneumococcal pneumosepsis APNA de Porto, TAM Claushuis, LEH van der Donk, R de Beer, ... Thrombosis and haemostasis 119 (06), 930-940, 2019 | 10 | 2019 |
| The evaluation and management of patients with LDL-C≥ 190 mg/dL in a large health care system CL Jackson, Z Ahmad, SR Das, A Khera American Journal of Preventive Cardiology 1, 100002, 2020 | 8 | 2020 |
| Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia CL Jackson, Y Deng, X Yao, H Van Houten, ND Shah, S Kopecky Journal of Clinical Lipidology 15 (2), 339-346, 2021 | 2 | 2021 |
| PCSK9 INHIBITOR UTILIZATION IN FAMILIAL HYPERCHOLESTEROLEMIA C Jackson, Y Deng, X Yao, H Van Houten, N Shah, S Kopecky Journal of the American College of Cardiology 75 (11_Supplement_1), 1873-1873, 2020 | | 2020 |
| March 10, 2020 volume 75 number 9 Z Almarzooq, B Collins, A Fatima, C Jackson, P Galazka, M Ramsis, ... | | 2020 |
| Cost Effectiveness of Cascade Testing for Familial Hypercholesterolemia in the US: A Simulation Analysis CL Jackson, T Huschka, BJ Borah, K Agre, M Zordok, M Farwati, ... Circulation 140 (Suppl_1), A11534-A11534, 2019 | | 2019 |
| IDENTIFYING FAMILIAL HYPERCHOLESTEROLEMIA USING A BLOOD DONOR SCREENING PROGRAM: RESULTS FROM> 200,000 DONORS C Wu, SJ Eason, Z Ahmad, C Ayers, MO Gore, D McGuire, M Sayers, ... Journal of the American College of Cardiology 71 (11S), A1732-A1732, 2018 | | 2018 |
| THE EVALUATION AND MANAGEMENT OF PATIENTS WITH LDL-C>= 190 MG/DL IN A LARGE HEALTH CARE SYSTEM C Wu, Z Ahmad, S Das, A Khera Journal of the American College of Cardiology 71 (11S), A1721-A1721, 2018 | | 2018 |
| Type 2 MI in Young Adults is Associated With High Cardiovascular Mortality: An 8-Year Follow-Up A Gupta, A Singh, A Qamar, B Collins, P Galazka, C Wu, EM DeFilippis, ... Circulation 136 (suppl_1), A17544-A17544, 2017 | | 2017 |
| Causes of Troponin Elevation and Associated Mortality in Young Adults C Wu, A Singh, B Collins, A Fatima, A Qamar, J Hainer, J Klein, P Jarolim, ... Circulation 136 (suppl_1), A16209-A16209, 2017 | | 2017 |
